HU-211, a novel noncompetitive N-methyl-D-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat - Belayev, L; Busto, R; Zhao, W; Ginsberg, M D (Stroke, 1995)
, discussion 2319–2320